Patients Report Memory Problems After Mild COVID-19
Patients who self-report memory problems eight months after COVID-19 often perceive worsening of health compared with one year prior
Dietary Flavonoids May Lower Odds of Subjective Cognitive Decline
Associations strongest for flavones, flavanones, anthocyanins; dose-response curve steepest for flavones, then anthocyanins
Report Questions Benefit of FDA Accelerated Approval Pathway
112 of the 253 authorized drugs have not been confirmed as clinically effective; 24 of these have been on market more than five years
U.S. Medical Debt High, but Varies Geographically
Debt higher in the South, in lowest income ZIP codes, and in states without Medicaid expansion
Metabolic Syndrome Linked to Increased Risk for Stroke Recurrence
Low levels of HDL cholesterol and having two or more components of metabolic syndrome predict recurrence
CT Findings Tied to Prognosis in Mild Traumatic Brain Injury
Certain pathological CT features associated with adverse outcomes up to one year after mild traumatic brain injury
Global Dementia Cases Projected to Top 152 Million in 2050
Increases in cases mainly due to population growth and aging, with relative importance of these factors varying by region
Long-Term Complications Common With Youth-Onset T2DM
Risk factors for development of complications include minority race or ethnic group, hyperglycemia, hypertension, dyslipidemia
Cognitive Impairment Reported After COVID-19 Infection
Cognitive impairment identified in cohort of older Amerindians and in 32 patients after mild-to-moderate COVID-19
Corneal Nerve Fiber Damage ID’d in Patients With Long COVID
Corneal small nerve fiber loss, increased dendritic cells seen in patients with neurological symptoms at four weeks after acute COVID-19
